Found: 6
Select item for more details and to access through your institution.
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).
- Published in:
- Movement Disorders, 2015, v. 30, n. 6, p. 788, doi. 10.1002/mds.26159
- By:
- Publication type:
- Article
Gene expression analysis by transcript profiling coupled to a gene database query.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 8, p. 798, doi. 10.1038/11743
- By:
- Publication type:
- Article
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0031006
- By:
- Publication type:
- Article
Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0029778
- By:
- Publication type:
- Article
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009332
- By:
- Publication type:
- Article
Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia.
- Published in:
- 2019
- By:
- Publication type:
- journal article